| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.001 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |